@FierceMedDev: Who are today's leading women in med tech? Check out our top women in medical devices list to find out. Special report | Follow @FierceMedDev
@VarunSaxena2: Invitae raises $120M to offer cheap, easy genetic analysis. Story | Follow @VarunSaxena2
@EmilyWFierce: $COV recalled some defibrillator electrodes made by $PHG. Story from MassDevice | Follow @EmilyWFierce
@MichaelGFierce: Stem cell-derived beta cells deliver insulin in response to blood sugar levels. Story | Follow @MichaelGFierce
> For the first time, Aethlon Medical used its Hemopurifier therapy on a patient infected with the Ebola virus. Release
> Harvard's Medical and Business schools put developing news device and diagnostics at the top of its list of the Deans' Health & Life Sciences Challenge. More
> Viewics, a CA-based startup, received $8 million in a funding round led by Canvas Venture Fund to use toward controlling hospitals' lab test costs. Story
Biotech News
@FierceBiotech: Meet some of the revolutionaries in biotech R&D. Report | Follow @FierceBiotech
@JohnCFierce: AbbVie to Shire: Maybe we should reconsider that $54B merger deal after all - $SHPG down 27%. Article | Follow @JohnCFierce
@DamianFierce: Fantastically timed press release: "Shire Announces the Organize Your Stuff Contest Winners." Release | Follow @DamianFierce
@EmilyMFierce: These 10 drugs could stop Ebola. Feature | Follow @EmilyMFierce
> Selecta banks $20M for trial work, inks a pact with Sanofi on diabetes. Story
> Forward Pharma pulls off a $221M IPO with eyes on unseating Biogen. More
> DNAtrix pockets $20M to get its cancer-fighting virus into Phase III. Article
Pharma News
@FiercePharma: Our newest special report is live! The top 10 most expensive drugs of 2013. Feature | Follow @FiercePharma
@EricPFierce: Novartis says construction delay of Russian plant no big deal, technical changes and not tied to sanctions. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Sanofi wins kudos for airing bribery probe. Phase II? Take to social media. Article | Follow @CarlyHFierce
> FDA grants a combo-med exclusivity wish. Why is that a problem? Story
> Former finance analyst charged in insider trading case. News
> AbbVie-Shire deal in jeopardy, but not necessarily dead. More
Drug Delivery News
> Robert Langer talks science, business and how they intersect. More
> Stem cell-derived beta cells deliver insulin in response to blood sugar levels. Story
> Stealthy, DNA-based 'nano-cocoons' deliver cancer-killing payloads. Report
> Alnylam releases data on its Phase II study of TTR-mediated amyloidosis patients. Item
> Intersect ENT says latest data on dissolving implants for chronic sinusitis are encouraging. Article
Diagnostics News
> Gene sequencing helps Northwestern team diagnose one cause of epilepsy. More
> Exact Sciences nails coveted Medicare coverage for colon cancer DNA test. News
> SomaLogic, CO hospital to develop biomarkers/Dx tests for childhood diseases. Story
> British startup finishes quick and easy Ebola test. Report
> Biocept, Rosetta Genomics want to beef up Dx and biomarker-detection power. Article
Pharma Marketing News
> Teva's SCOTUS appeal is here. But how much can the outcome really affect Copaxone's market share? More
> World's best CEOs? Gilead, Allergan, Novo and Valeant make top 10. Read
> Looking 'beyond the pill'? Start with an app--and then follow this to-do list. Story
> Can Amgen's marketing muscle vault its Humira biosim ahead of rivals? More
> Pictures tell the story in AstraZeneca's breast cancer photo-sharing push. Article